Results 271 to 280 of about 425,993 (391)

Ubiquitination dynamics in human tumour viruses: Viral infection, oncogenesis and antiviral therapy

The FEBS Journal, EarlyView.
The ubiquitin system is essential for cellular homeostasis and regulates many processes. Viruses, including oncogenic ones, exploit or evade this system to survive and replicate. This review explores how human tumour viruses manipulate the ubiquitination system to complete their life cycle, evade immunity and promote cancer.
Oscar Trejo‐Cerro, Martina Bergant Marušič, Justyna Broniarczyk   +2 more
wiley   +1 more source

Anti-hepatitis C virus threshold value in predicting hepatitis C virus viremia in hemodialysis patients. [PDF]

Rev Assoc Med Bras (1992)
Sarıkaya VA, Ayan U, Aksaray S, Erdinç S, Sarıkaya B, Balık R, Şenbayrak S, Erol S, İnan A, Ceran N.   +9 more
europepmc   +1 more source

A Study of HCV Antibody in AMHTS

, 1994

openalex   +2 more sources

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.

Gastroenterology, 2016
C. Sarrazin, H. Dvory‐Sobol, E. Svarovskaia, B. Doehle, P. Pang, S. Chuang, Julie Ma, Xiao Ding, N. Afdhal, K. Kowdley, E. Gane, E. Lawitz, D. Brainard, J. Mchutchison, Michael D. Miller, H. Mo   +15 more
semanticscholar   +1 more source

Dynamics of the CD9 interactome during bacterial infection of epithelial cells by proximity labelling proteomics

The FEBS Journal, EarlyView.
We describe the CD9 interactome in epithelial cells for the first time. The interactome is diverse and dynamic and changes dependent on infection with specific bacteria. We validate these data by showing functional interaction between CD9 with CD44 or CD147. We therefore demonstrate that CD9 is a universal organiser of bacterial adhesion platforms able
Paige A. Wolverson, Isabel Fernandes Parreira, Ruth H. Thompson, Mark O. Collins, Jonathan G. Shaw, Luke R. Green   +5 more
wiley   +1 more source

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication” [PDF]

Clinical and Molecular Hepatology
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu   +3 more
doaj   +1 more source

Results of Detection of HCV Antibody in Hakuaikai Multiphasic Health Testing and Services

, 1993
原田 美智子, 仁位 千春, 下条 サツコ, 桜井 智子, 瀬戸 純子, 豊田 真由子, 小田 千恵美, 峰中 直美, 那須 繁, 広津留 〓子, 矢野 隆, 滝下 信之   +11 more
openalex   +2 more sources

Risk of HCV After Occupational Exposure [PDF]

, 1996
Gina Pugliese
openalex   +1 more source

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

New England Journal of Medicine, 2014
P. Ferenci, D. Bernstein, J. Lalezari, D. Cohen, Yan Luo, C. Cooper, E. Tam, R. Marinho, N. Tsai, A. Nyberg, T. Box, Z. Younes, P. Enayati, Sinikka Green, Y. Baruch, B. Bhandari, F. Căruntu, T. Sepe, Vladimir P Chulanov, E. Janczewska, G. Rizzardini, J. Gervain, R. Planas, Christophe Moreno, T. Hassanein, W. Xie, M. King, T. Podsadecki, K. Reddy   +28 more
semanticscholar   +1 more source

Navigating the Transition From Adolescence to Adulthood Among Young People With Severe Haemophilia: The Qualitative Phase of the TRANSHEMO Project

Haemophilia, EarlyView.
ABSTRACT Introduction Haemophilia causes spontaneous or prolonged bleeding due to a deficiency in clotting factor VIII (haemophilia A) or IX (haemophilia B). Although substitutive therapies and regular follow‐up can prevent severe haemorrhagic events, adherence to treatment remains a challenge.
Marie‐Anaïs Roques, Natacha Rosso‐Delsemme, Amandine Celli, Ngoc Anh Thu Nguyen, Martin Postzich, Sabine Castet, Yoann Huguenin, Annie Harroche, Anne Lienhart, Sandrine Meunier, Christine Biron‐Andréani, Florence Rousseau, Roseline d'Oiron, Yohann Repessé, Clémence Tabélé, Any Beltran Anzola, Thomas Sannié, Nicolas Giraud, Pascal Auquier, Hervé Chambost, Noémie Resseguier, The TRANSHEMO Study Group, Thémis Apostolidis, Laurent Ardillon, Karine Baumstarck, Sophie Bayart, Claire Berger, Marie‐Anne Bertrand, Carol Betsch, Annie Borel‐Derlon, Mohamed Boucekine, Thierry Calvez, Pierre Chamouni, Ségolène Claeyssens Donadel, Yannick Colle, Yesim Dargaud, Emmanuelle de Raucourt, Dominique Desprez, Céline Falaise, Alexandra Fournel, Birgit Frotscher, Valérie Gay, Fabienne Genre‐Volot, Jenny Goudemand, Yves Gruel, Benoît Guillet, Abel Hassoun, Audrey Hochart, Thierry Lambert, Aurélien Lebreton, Tanguy Leroy, Raphaël Marlu, Michèle Martin, Vanessa Milien, Fabrice Monpoux, Pierre Morange, Guillaume Mourey, Claude Negrier, Philippe Nguyen, Placide Nyombe, Caroline Oudot‐Challard, Brigitte Pan‐Petesch, Benoît Polack, Anne Rafowicz, Antoine Rauch, Delphine Rivaud, Pierre‐Simon Rohrlich, Pascale Schneider, Alexandra Spiegel, Cécile Stoven, Sophie Susen, Brigitte Tardy, Marc Trossaërt, Jean‐Baptiste Valentin, Stéphane Vanderbecken, Marie Viprey, Romain Voltzenlogel, Annelise Voyer‐Ebrard, Bénédicte Wibaut   +78 more
wiley   +1 more source